Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
02 2022
Historique:
entrez: 14 2 2022
pubmed: 15 2 2022
medline: 27 4 2022
Statut: ppublish

Résumé

The global pediatric oncology clinical research landscape, particularly in Central and South America, Africa, and Asia, which bear the highest burden of global childhood cancer cases, is less characterized in the literature. Review of how existing pediatric cancer clinical trial groups internationally have been formed and how their research goals have been pursued is critical for building global collaborative research and data-sharing efforts, in line with the WHO Global Initiative for Childhood Cancer. A narrative literature review of collaborative groups performing pediatric cancer clinical research in each continent was conducted. An inventory of research groups was assembled and reviewed by current pediatric cancer regional and continental leaders. Each group was narratively described with identification of common structural and research themes among consortia. There is wide variability in the structure, history, and goals of pediatric cancer clinical trial collaborative groups internationally. Several continental regions have longstanding endogenously-formed clinical trial groups that have developed and published numerous adapted treatment regimens to improve outcomes, whereas other regions have consortia focused on developing foundational database registry infrastructure supported by large multinational organizations or twinning relationships. There cannot be a one-size-fits-all approach to increasing collaboration between international pediatric cancer clinical trial groups, as this requires a nuanced understanding of local stakeholders and resources necessary to form partnerships. Needs assessments, performed either by local consortia or in conjunction with international partners, have generated productive clinical trial infrastructure. To achieve the goals of the Global Initiative for Childhood Cancer, global partnerships must be sufficiently granular to account for the distinct needs of each collaborating group and should incorporate grassroots approaches, robust twinning relationships, and implementation science.

Identifiants

pubmed: 35157510
doi: 10.1200/GO.21.00266
pmc: PMC8853619
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2100266

Références

J Clin Oncol. 2015 Sep 20;33(27):3065-73
pubmed: 26304881
J Clin Oncol. 2009 Mar 10;27(8):1297-303
pubmed: 19164215
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Pediatr Blood Cancer. 2017 Dec;64 Suppl 5:
pubmed: 29297619
Pediatr Blood Cancer. 2018 Jul;65(7):e27056
pubmed: 29630767
Pediatr Blood Cancer. 2014 Aug;61(8):1403-10
pubmed: 24648275
J Pediatr Hematol Oncol. 2012 Mar;34 Suppl 1:S32-5
pubmed: 22357150
Nat Rev Clin Oncol. 2013 Oct;10(10):599-604
pubmed: 23897077
Pediatr Blood Cancer. 2008 Aug;51(2):241-4
pubmed: 18300320
JCO Glob Oncol. 2020 Aug;6:1328-1345
pubmed: 32886560
Biomed Res Int. 2015;2015:576950
pubmed: 25922837
Cancer. 1977 Oct;40(4):1402-9
pubmed: 269004
Lancet Oncol. 2019 Apr;20(4):483-493
pubmed: 30824204
Rev Bras Hematol Hemoter. 2011;33(5):326-7
pubmed: 23049330
Genet Med. 2006 Dec;8(12):793-6
pubmed: 17172943
S Afr Med J. 2014 May 19;104(7):501-4
pubmed: 25214053
Pediatr Hematol Oncol. 2020 May;37(4):300-313
pubmed: 32075464
Blood. 2018 Jul 26;132(4):405-412
pubmed: 29789356
J Glob Oncol. 2019 Mar;5:1-10
pubmed: 30917070
J Oncol Pract. 2019 Aug;15(8):445-446
pubmed: 31404511
Pediatr Blood Cancer. 2016 Nov;63 Suppl 3:S5-S321
pubmed: 27673274
Pediatr Blood Cancer. 2018 May;65(5):e26945
pubmed: 29350457
Pediatr Blood Cancer. 2015 Oct;62(10):1747-53
pubmed: 25917418
Pediatr Blood Cancer. 2018 Feb;65(2):
pubmed: 28960700
Pediatr Blood Cancer. 2008 Jun;50(6):1143-6
pubmed: 18085687
Pediatr Blood Cancer. 2013 Sep;60(9):1464-9
pubmed: 23606223
JAMA Oncol. 2020 Mar 1;6(3):358-366
pubmed: 31944221
BMC Cancer. 2019 Oct 16;19(1):961
pubmed: 31619207
Lancet Oncol. 2008 Feb;9(2):159-67
pubmed: 18237850
Pediatr Blood Cancer. 2019 Oct;66(10):e27898
pubmed: 31264788
J Pediatr Hematol Oncol. 2016 Jul;38(5):372-7
pubmed: 27164527
J Glob Oncol. 2019 Sep;5:1-8
pubmed: 31487216
Eur J Cancer. 2015 Jan;51(1):84-91
pubmed: 25465189
Ecancermedicalscience. 2019 May 28;13:932
pubmed: 31281429
J Trop Pediatr. 2021 Jul 2;67(3):
pubmed: 33020840
South Asian J Cancer. 2016 Jul-Sep;5(3):155-60
pubmed: 27606304
Hematology. 2005;10 Suppl 1:3-5
pubmed: 16188621
Rev Panam Salud Publica. 2017 Dec 05;41:e152
pubmed: 31384271
J Glob Oncol. 2019 Oct;5:1-12
pubmed: 31657980
Lancet Oncol. 2013 Mar;14(3):e104-16
pubmed: 23434340
Pediatr Blood Cancer. 2017 Oct;64(10):
pubmed: 28383768
Med Pediatr Oncol. 1994;22(4):258-60
pubmed: 8107657
Lancet Oncol. 2012 Sep;13(9):936-45
pubmed: 22898679
JCO Clin Cancer Inform. 2021 Sep;5:1034-1043
pubmed: 34662145
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1133-1137
pubmed: 31030486
Leukemia. 2010 Feb;24(2):397-405
pubmed: 20016538
J Glob Oncol. 2018 Jul;4:1-12
pubmed: 30084750
Pediatr Blood Cancer. 2021 Sep;68(9):e29224
pubmed: 34245212
Leukemia. 2005 Dec;19(12):2143-6
pubmed: 16304574
JCO Glob Oncol. 2020 Jul;6:1076-1078
pubmed: 32673078
Saudi Med J. 2021 Mar;42(3):345-346
pubmed: 33632918
J Pediatr Oncol Nurs. 2019 Jan/Feb;36(1):24-34
pubmed: 30426816
Pediatr Blood Cancer. 2014 Feb;61(2):345-54
pubmed: 24376230
Pediatr Investig. 2020 Sep 27;4(3):153-156
pubmed: 33150308
J Clin Oncol. 2019 Nov 1;37(31):2875-2882
pubmed: 31536438
Pediatr Blood Cancer. 2018 Dec;65(12):e27298
pubmed: 30094928
J Korean Med Sci. 2020 Nov 30;35(46):e393
pubmed: 33258329
Ann Oncol. 2004 Apr;15(4):680-5
pubmed: 15033679
Pediatr Blood Cancer. 2020 Nov;67(11):e28667
pubmed: 32827347
Pediatr Blood Cancer. 2018 Jan;65(1):
pubmed: 28675683
Eur J Cancer. 1997 Aug;33(9):1439-47
pubmed: 9337687
South Asian J Cancer. 2014 Jan;3(1):78-82
pubmed: 24665454
Lancet. 2015 Mar 14;385(9972):977-1010
pubmed: 25467588
Leukemia. 1993 Aug;7 Suppl 2:S142-5
pubmed: 8361220
Lancet Oncol. 2019 Jul;20(7):972-983
pubmed: 31129029
JAMA Ophthalmol. 2018 Jul 1;136(7):747-752
pubmed: 29799944
J Ophthalmol. 2020 Aug 10;2020:1953602
pubmed: 32850140
JCO Glob Oncol. 2020 Aug;6:1264-1275
pubmed: 32762563
Pediatr Blood Cancer. 2012 Jan;58(1):37-42
pubmed: 21850676
Cancer Epidemiol. 2021 Apr;71(Pt B):101727
pubmed: 32499117
J Glob Oncol. 2019 Nov;5:1-9
pubmed: 31794283
J Pediatr Hematol Oncol. 2011 Oct;33 Suppl 2:S154-6
pubmed: 21952575
Lancet Oncol. 2019 Sep;20(9):e493-e502
pubmed: 31395474
Pediatr Blood Cancer. 2014 Jun;61(6):997-1002
pubmed: 24347509
Cancer Epidemiol. 2017 Oct;50(Pt B):193-198
pubmed: 29120825
JCO Glob Oncol. 2020 Oct;6:1531-1539
pubmed: 33064626
Cancer. 2010 Nov 1;116(21):5063-74
pubmed: 20629033
J Clin Oncol. 2010 Apr 10;28(11):1911-8
pubmed: 20212252
Rev Assoc Med Bras (1992). 2020 Mar;66(3):284-289
pubmed: 32520146
Blood. 2020 Oct 15;136(16):1813-1823
pubmed: 32845001
Int J Clin Oncol. 2018 Oct;23(5):965-973
pubmed: 29700636
Int J Cancer. 2018 Nov 15;143(10):2409-2415
pubmed: 29981149
Cancer. 2020 Nov 15;126(22):4984-4993
pubmed: 32813913
Lancet Oncol. 2016 Jun;17(6):701-703
pubmed: 27299263
Med Pediatr Oncol. 1999 Aug;33(2):88-94
pubmed: 10398182
Lancet Oncol. 2017 Jun;18(6):709-711
pubmed: 28593842
JCO Glob Oncol. 2020 Nov;6:1791-1802
pubmed: 33216645
Pediatr Blood Cancer. 2019 May;66(5):e27621
pubmed: 30677231
J Clin Oncol. 2015 Sep 20;33(27):2975-85
pubmed: 26304892
Lancet Oncol. 2015 Oct;16(14):1401-3
pubmed: 26522155
Am J Hematol. 2018 Jul;93(7):913-920
pubmed: 29675840
Pediatr Blood Cancer. 2021 Dec;68(12):e29367
pubmed: 34549506
Pediatr Blood Cancer. 2012 Sep;59(3):454-60
pubmed: 22610685
Int J Cancer. 2021 Jun 1;148(11):2685-2691
pubmed: 33433927
Semin Oncol. 2008 Oct;35(5):484-93
pubmed: 18929147
J Natl Cancer Inst. 2021 Jan 4;113(1):9-15
pubmed: 32433739
Pediatr Blood Cancer. 2016 Mar;63(3):387-91
pubmed: 26797891
Int J Epidemiol. 2022 Feb 18;51(1):314-323
pubmed: 34368848

Auteurs

Ajay Major (A)

Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL.

Monica Palese (M)

Department of Pediatrics, University of Chicago, Chicago, IL.

Ebru Ermis (E)

Department of Pediatrics, University of Chicago, Chicago, IL.

Anthony James (A)

Department of Pediatrics, University of Chicago, Chicago, IL.

Milena Villarroel (M)

Grupo de América Latina de Oncología Pediátrica (GALOP), Hospital Luis Calvo Mackenna, National Pediatric Cancer Program (PINDA), Santiago, Chile.

Federico Antillon Klussmann (FA)

National Unit of Pediatric Oncology, Francisco Marroquin University School of Medicine, Guatemala City, Guatemala.

Laila Hessissen (L)

Pediatric Hematology and Oncology, Mohammed V University of Rabat, Rabat, Morocco.

Jennifer Geel (J)

Faculty of Health Sciences, Division of Pediatric Haematology and Oncology, Department of Pediatrics and Child Health, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Muhammad Saghir Khan (MS)

Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Al Madinah, Saudi Arabia.

Rashmi Dalvi (R)

Bombay Hospital Institute of Medical Sciences and SRCC Children's Hospital, Mumbai, India.

Michael Sullivan (M)

Children's Cancer Centre, Royal Children's Hospital, Melbourne, Australia.

Pamela Kearns (P)

Cancer Research UK Clinical Trials Unit, National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Cancer and Genomic Sciences, Birmingham, United Kingdom.

A Lindsay Frazier (AL)

Dana-Farber Cancer Institute, Boston, MA.

Kathy Pritchard-Jones (K)

UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Akira Nakagawara (A)

Ion Beam Therapy Center, SAGA HIMAT Foundation, Saga, Japan.

Carlos Rodriguez-Galindo (C)

Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN.

Samuel L Volchenboum (SL)

Department of Pediatrics, University of Chicago, Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH